Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 116

1.

Perinephric invasion as a prognostic factor in non-metastatic renal cell carcinoma: analysis of a nation-wide registry program.

Kume H, Homma Y, Shinohara N, Obara W, Kondo T, Kimura G, Fujimoto H, Nonomura N, Hongo F, Sugiyama T, Takahashi M, Kanayama HO, Fukumori T, Eto M.

Jpn J Clin Oncol. 2019 Apr 12. pii: hyz054. doi: 10.1093/jjco/hyz054. [Epub ahead of print]

PMID:
30977820
2.

Low Expression of Toll-like Receptor 4 Is Associated With Poor Prognosis in Bladder Cancer.

Kusuhara Y, Daizumoto K, Kawai K, Hirayama K, Kowada M, Shintani T, Fukuhara Y, Dondoo TO, Ozaki K, Tsuda M, Fukawa T, Nakatsuji H, Bando Y, Uehara H, Fukumori T, Takahashi M, Kanayama HO.

Anticancer Res. 2019 Feb;39(2):703-711. doi: 10.21873/anticanres.13166.

PMID:
30711948
3.

Prospective study of robotic partial nephrectomy for renal cancer in Japan: Comparison with a historical control undergoing laparoscopic partial nephrectomy.

Tanaka K, Teishima J, Takenaka A, Shiroki R, Kobayashi Y, Hattori K, Kanayama HO, Horie S, Yoshino Y, Fujisawa M.

Int J Urol. 2018 May;25(5):472-478. doi: 10.1111/iju.13544. Epub 2018 Apr 19.

4.

A DDX31/Mutant-p53/EGFR Axis Promotes Multistep Progression of Muscle-Invasive Bladder Cancer.

Daizumoto K, Yoshimaru T, Matsushita Y, Fukawa T, Uehara H, Ono M, Komatsu M, Kanayama HO, Katagiri T.

Cancer Res. 2018 May 1;78(9):2233-2247. doi: 10.1158/0008-5472.CAN-17-2528. Epub 2018 Feb 13.

5.

Current knowledge of risk factors for testicular germ cell tumors.

Fukawa T, Kanayama HO.

Int J Urol. 2018 Apr;25(4):337-344. doi: 10.1111/iju.13519. Epub 2018 Jan 17. Review.

6.

Author's Reply to Oka and Colleagues.

Nagai K, Tsuchida K, Ishihara N, Minagawa N, Ichien G, Yamada S, Hirose D, Michiwaki H, Kanayama HO, Doi T, Minakuchi J.

Ther Apher Dial. 2018 Feb;22(1):96-97. doi: 10.1111/1744-9987.12655. Epub 2018 Jan 9. No abstract available.

PMID:
29316262
7.

Active heavy cigarette smoking is associated with poor survival in Japanese patients with advanced renal cell carcinoma: sub-analysis of the multi-institutional national database of the Japanese Urological Association.

Hara T, Fujimoto H, Kondo T, Shinohara N, Obara W, Kimura G, Kume H, Nonomura N, Hongo F, Sugiyama T, Kanayama HO, Takahashi M, Fukumori T, Eto M; Cancer Registration Committee of the Japanese Urological Association.

Jpn J Clin Oncol. 2017 Dec 1;47(12):1162-1169. doi: 10.1093/jjco/hyx129.

PMID:
29121328
8.

Prognostic factors for mortality in middle-aged and older hemodialysis patients: a 5-year observational study.

Nagai K, Matsuura M, Tsuchida K, Kanayama HO, Doi T, Minakuchi J.

J Artif Organs. 2018 Mar;21(1):94-101. doi: 10.1007/s10047-017-0993-2. Epub 2017 Sep 16.

PMID:
28918555
9.

Recognizing the Continuous Nature of Expression Heterogeneity and Clinical Outcomes in Clear Cell Renal Cell Carcinoma.

Wei X, Choudhury Y, Lim WK, Anema J, Kahnoski RJ, Lane B, Ludlow J, Takahashi M, Kanayama HO, Belldegrun A, Kim HL, Rogers C, Nicol D, Teh BT, Tan MH.

Sci Rep. 2017 Aug 4;7(1):7342. doi: 10.1038/s41598-017-07191-y.

10.

An In Vitro Study of a New Device: Evaluation of Novel Wide-Angle Lens Flexible Cystoscope Using Phantom Bladder Model.

Yamaguchi K, Inoue T, Habuchi T, Inokuchi J, Yokomizo A, Eto M, Kanayama HO.

J Endourol. 2017 Oct;31(10):1073-1078. doi: 10.1089/end.2017.0371.

PMID:
28726499
11.

Predictive Factors for Prolonged Urination Disorder After Permanent 125I Brachytherapy for Localized Prostate Cancer.

Mori H, Fukumori T, Daizumoto K, Tsuda M, Kusuhara Y, Fukawa T, Yamamoto Y, Yamaguchi K, Takahashi M, Kubo A, Kawanaka T, Furutani S, Ikushima H, Kanayama HO.

In Vivo. 2017 Jul-Aug;31(4):755-761.

12.

Implications of Albumin Leakage for Survival in Maintenance Hemodialysis Patients: A 7-year Observational Study.

Nagai K, Tsuchida K, Ishihara N, Minagawa N, Ichien G, Yamada S, Hirose D, Michiwaki H, Kanayama HO, Doi T, Minakuchi J.

Ther Apher Dial. 2017 Aug;21(4):378-386. doi: 10.1111/1744-9987.12526. Epub 2017 Apr 27.

PMID:
28452109
13.

Galectin-3 Is Implicated in Tumor Progression and Resistance to Anti-androgen Drug Through Regulation of Androgen Receptor Signaling in Prostate Cancer.

Dondoo TO, Fukumori T, Daizumoto K, Fukawa T, Kohzuki M, Kowada M, Kusuhara Y, Mori H, Nakatsuji H, Takahashi M, Kanayama HO.

Anticancer Res. 2017 Jan;37(1):125-134.

PMID:
28011482
14.

Scientific Skill Assessment of Basic Surgical Dissection and Overall Laparoscopic Performance.

Matsuda T, Yoshida K, Habuchi T, Kinoshita H, Kanayama HO, Terachi T.

J Endourol. 2017 Apr;31(S1):S25-S29. doi: 10.1089/end.2016.0554. Epub 2016 Sep 23.

PMID:
27558152
15.

Excessive fatty acid oxidation induces muscle atrophy in cancer cachexia.

Fukawa T, Yan-Jiang BC, Min-Wen JC, Jun-Hao ET, Huang D, Qian CN, Ong P, Li Z, Chen S, Mak SY, Lim WJ, Kanayama HO, Mohan RE, Wang RR, Lai JH, Chua C, Ong HS, Tan KK, Ho YS, Tan IB, Teh BT, Shyh-Chang N.

Nat Med. 2016 Jun;22(6):666-71. doi: 10.1038/nm.4093. Epub 2016 May 2.

PMID:
27135739
16.

Depot- and gender-specific expression of NLRP3 inflammasome and toll-like receptors in adipose tissue of cancer patients.

Shimabukuro M, Sato H, Izaki H, Fukuda D, Uematsu E, Hirata Y, Yagi S, Soeki T, Sakaue H, Kanayama HO, Masuzaki H, Sata M.

Biofactors. 2016 Jul 8;42(4):397-406. doi: 10.1002/biof.1287. Epub 2016 Apr 18.

PMID:
27086574
17.

The effect of albumin leakage in hemodialysis patients on redox status of serum albumin.

Nagai K, Tsuchida K, Hirose D, Michiwaki H, Hann M, Kanayama HO, Doi T, Minakuchi J.

J Artif Organs. 2016 Sep;19(3):310-4. doi: 10.1007/s10047-016-0900-2. Epub 2016 Apr 16.

PMID:
27086124
18.

Clinical Significance of Neoadjuvant Combined Androgen Blockade for More Than Six Months in Patients with Localized Prostate Cancer Treated with Prostate Brachytherapy.

Senzaki T, Fukumori T, Mori H, Kusuhara Y, Komori M, Kagawa J, Fukawa T, Yamamoto Y, Yamaguchi K, Takahashi M, Kubo A, Kawanaka T, Furutani S, Ikushima H, Kanayama HO.

Urol Int. 2015;95(4):457-64. doi: 10.1159/000439573. Epub 2015 Oct 14.

PMID:
26461847
19.

Vascular access for long-term hemodialysis/hemodiafiltration patients.

Yokota N, Nagai K, Okada D, Muromiya Y, Suenaga T, Ueda Y, Kawahara K, Kanayama HO, Minakuchi J, Tsuchida K.

J Vasc Access. 2015 Nov;16 Suppl 10:S18-21. doi: 10.5301/jva.5000427. Epub 2015 Sep 26.

PMID:
26429128
20.

Reduction or discontinuation of antibiotic prophylaxis in vascular access surgery, tendon sheath incision and PD catheter placement.

Nagai K, Tsuchida K, Sasada M, Yokota N, Nishitani M, Kanayama HO, Minakuchi J.

J Vasc Access. 2015 Nov;16 Suppl 10:S66-9. doi: 10.5301/jva.5000423. Epub 2015 Sep 3.

PMID:
26349895

Supplemental Content

Loading ...
Support Center